Publication
Title
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer
Author
Abstract
Language
English
Source (journal)
European journal of cancer
Publication
2018
ISSN
0959-8049
1879-0852
Volume/pages
103(2018), p. 184-194
ISI
000447292100023
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 09.11.2018
Last edited 13.12.2018
To cite this reference